Details of the Drug Formulations

General Information of Drug (ID: DMWV2AG)

Drug Name
Ceftibuten Drug Info
Synonyms
CETB; Cedax; Ceftem; Ceftibutene; Ceftibuteno; Ceftibutenum; Cephem; Ceprifran; Isocef; Keimax; Antibiotic 7432S; S 7432; Sch 39720; Cedax (TN); Ceftibutene [INN-French]; Ceftibuteno [INN-Spanish]; Ceftibutenum [INN-Latin]; Cephalosporin 7432-S; Cis-Ceftibutin; Cis-ceftibuten; Sch-39720; Trans-Ceftibuten; Ceftibuten(USAN/INN); Ceftibuten [USAN:INN:BAN]; (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7432-S; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Acute otitis media AB00 Approved [1]
Chronic bronchitis CA20.1 Approved [2]
Pars planitis Approved [1]
Therapeutic Class
Antibiotics
Cross-matching ID
PubChem CID
5282242
ChEBI ID
CHEBI:3510
CAS Number
97519-39-6
TTD ID
D05JDR
VARIDT ID
DR00537
ACDINA ID
D00111

Full List of Drug Formulations Containing This Drug

Ceftibuten 400 mg capsule
Company Formulation ID FDA Description
Macoven Pharmaceuticals; Pernix Therapeutics F03680 Methylparaben; Sodium lauryl sulfate; Butylparaben; Benzyl alcohol; Magnesium stearate; Propylparaben; Sodium propionate; Edetate calcium disodium; Titanium dioxide; Polysorbate 80; Cellulose, microcrystalline; Gelatin; Sodium starch glycolate type a potato
Sciele Pharma, Inc. F03681 Methylparaben; Sodium lauryl sulfate; Butylparaben; Benzyl alcohol; Propylparaben; Sodium propionate; Edetate calcium disodium; Titanium dioxide; Polysorbate 80; Gelatin
------------------------------------------------------------------------------------
Ceftibuten Dihydrate eq 400mg base capsule
Company Formulation ID FDA Description
F23339 Cherry Flavoring; Polysorbate 80; Silicon Dioxide; Simethicone; Sodium Benzoate; Sucrose; Titanium Dioxide; Xanthan Gum
------------------------------------------------------------------------------------

References

1 Ceftibuten FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015